| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |